Intismeran:First successful Phase 3 trial for Personalised Vaccines

Vaccines have been the most successful tool in public health for over 150 years. But up to now they have been generic: each one is raised and designed against a specific disease-such as rabies, smallpox and more recently malaria. A new class of vaccine changes that logic entirely. These are individualised neoantigen vaccines, built from … Continue reading Intismeran:First successful Phase 3 trial…